Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb;31(1):145-154.
doi: 10.1016/j.coms.2018.09.003.

Current Concepts in Chemotherapy for Head and Neck Cancer

Simran K Sindhu  1 , Julie E Bauman  2
Affiliations
Review

Current Concepts in Chemotherapy for Head and Neck Cancer

Simran K Sindhu et al. Oral Maxillofac Surg Clin North Am. 2019 Feb.

Abstract

This article highlights the evidence-based data to support systemic treatment options for patients with head and neck squamous cell carcinoma (HNSCC). The discovery of the human papillomavirus epidemic in HNSCC and its favorable prognosis has led to a major focus of research. Patients are stratified into clinical or pathologic risk categories and enrolled in trials comparing standard treatment paradigms with deintensification, in low-risk disease, or to intensification, in intermediate-risk or high-risk disease. Immunotherapy has proven beneficial in second-line palliative therapy and is under investigation in first-line palliative therapy and as a component of definitive, multimodality therapy for high-risk patients.

Keywords: Chemotherapy; Deintensification; HPV-associated oropharyngeal squamous cell carcinoma (HPV-OPSCC); Head and neck squamous cell carcinoma (HNSCC); Previously untreated locally advanced (PULA) head and neck cancer.

PubMed Disclaimer

References

    1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136(5):E359–86. - PubMed
    1. Allen C, Duffy S, Teknos T, et al. Nuclear factor-kappaB-related serum factors as longitudinal biomarkers of response and survival in advanced oropharyngeal carcinoma. Clin Cancer Res 2007; 13(11):3182–90. - PubMed
    1. Leibowitz MS, Andrade Filho PA, Ferrone S, et al. Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes. Cancer Immunol Immun-other 2011;60(4):525–35. - PMC - PubMed
    1. Kuss I, Hathaway B, Ferris RL, et al. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res 2004;10(11): 3755–62. - PubMed
    1. Whiteside TL. Immunobiology of head and neck cancer. Cancer Metastasis Rev 2005;24(1):95–105. - PubMed

MeSH terms

Substances